Abstract:The hydrophobicity of many chemotherapeutic agents usually results in their nonselective passive distribution into healthy cells and organs causing collateral toxicity. Ligand-targeted drugs (LTDs) are a promising class of targeted anticancer agents. The hydrophilicity of the targeting ligands in LTDs limits its nonselective passive tissue distribution and toxicity to healthy cells. In addition, the small size of LTDs allows for better tumor penetration, especially in the case of solid tumors. However, the short circulation half-life of LTDs, due to their hydrophilicity and small size, remains a significant challenge for achieving their full therapeutic potential. Therefore, extending the circulation half-life of targeted chemotherapeutic agents while maintaining their hydrophilicity and small size will represent a significant advance toward effective and safe cancer treatment. Here, we present a new approach for enhancing the safety and efficacy of targeted chemotherapeutic agents. By endowing hydrophobic chemotherapeutic agents with a targeting moiety and a hydrophilic small molecule that binds reversibly to the serum protein transthyretin, we generated small hydrophilic drug conjugates that displayed enhanced circulation half-life in rodents and selectivity to cancer cells. To the best of our knowledge, this is the first demonstration of a successful approach that maintains the small size and hydrophilicity of targeted anticancer agents containing hydrophobic payloads while at the same time extending their circulation half-life. This was demonstrated by the superior in vivo efficacy and lower toxicity of our conjugates in xenograft mouse models of metastatic prostate cancer.

Hydrophobic tagging of small molecules: an overview of the literature and future outlook

Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation Miniperspective

Hydrophobic tag-based protein degradation: Development, opportunity and challenge

Development of Novel Silicon-Based Hydrophobic Tags (SiHyT) for Targeted Proteins Degradation

Methods to Profile the Macromolecular Targets of Small Compounds.

Discovery of Norbornene As a Novel Hydrophobic Tag Applied in Protein Degradation

Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules

Hydrophobic Tag Tethering Degrader As a Promising Paradigm of Protein Degradation: Past, Present and Future Perspectives

Graphisches Inhaltsverzeichnis: Angew. Chem. 34/2022

Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties

A novel hydrophobic tag leads to the efficient degradation of programmed death-ligand 1

Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells.

Fluorous Tagging Strategy for Solution‐Phase Synthesis of Small Molecules, Peptides and Oligosaccharides

Hydrogen Isotope Labeling of Pharmaceuticals via Dual Hydrogen Isotope Exchange Pathways

Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents

The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs

The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.

Mechanism-Based Strategy for Optimizing HaloTag Protein Labeling

Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools for Monitoring Targeted Protein Degradation

Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond

Small Molecule PROTACs in Targeted Therapy: an Emerging Strategy to Induce Protein Degradation.